Latona acquires patent rights and orphan drug status to drug compound for rheumatoid arthritis
Latona Life Sciences Inc. announced today that it has entered into two agreements for the acquisition of patent rights and orphan drug status to a novel late-stage drug, trademarked “Oralgam,” for the treatment of Juvenile and Adult Rheumatoid Arthritis.(original article)
Buy Methadone
Buy Carvedilol
Buy Tobramycin
Buy Nefazodone
Buy Midodrine
Buy Arava
Buy Cefdinir
Buy Premarin
Buy Cordarone
Buy Naprosyn
Buy Cefprozil
Buy Enoxaparin
Buy Medrol
Buy Amantadine
Buy Diethylstilbestrol
Buy Fentanyl
Buy Paxil
Buy Kanamycin
Buy Didrex
Buy Zyrtec
Buy Zuclopenthixol
Buy Levoxyl
Buy Senna
Buy Aspirin
Buy Corticotropin
Buy Vasopressin
Buy Chlorpheniramine
Buy Nitroprusside
Buy Lansoprazole
Buy Anisotropine
Buy Nevirapine
Buy Dutasteride
Buy Naltrexone
Buy Omeprazole
Buy Eulexin
Buy Thiothixene
Buy Flurazepam
Buy Trovafloxacin
Buy Paromomycin
Buy Methicillin
Buy Zetia
Buy Divalproex
Buy Oxycontin
Buy Chlordiazepoxide
Buy Aurothioglucose
Buy Methsuximide
Buy Hexamethonium
Buy Minoxidil
Buy Botox
Buy Dextromethorphan
Buy Cyclacillin
Buy Trandolapril
Buy Terfenadine
Buy Levaquin
Buy Digitoxin
Buy Colistimethate
Buy Sulfasalazine
Buy Nifedipine
Buy Fluorouracil
Buy Micronase
Buy Bactrim
Buy Alavert
Buy Dihydrotachysterol
Buy Mefloquine
Buy Tetanus
Buy Bentyl
Buy Homatropine
Buy Dalteparin
Buy Zantac
Buy Mebanazine
Buy Sumatriptan
Buy Alfentanil
Buy Minocycline
Buy Loperamide
Buy Vinblastine
Buy Novobiocin
Buy Lamivudine
Comments are closed.

